In addition to being the strongest RA risk factor, MHC molecules distinguished CDC42hiCD14+ cells with efficient antigen presenting ability that accumulate the signals and mediate them further, thus coordinating the activity of the innate and adaptive immunity at the site of inflammation. This evidence concerns the gene HLA-C and rheumatoid arthritis.